Trial Profile
HIV-positive Patients Under Tenofovir, Emtricitabine and Efavirenz Therapy Switching From a Two-pill Regimen to a Single Pill Regimen: Patients' Opinion Survey
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Efavirenz/emtricitabine/tenofovir-disoproxil-fumarate (Primary) ; Efavirenz; Emtricitabine; Emtricitabine/tenofovir disoproxil fumarate; Tenofovir disoproxil fumarate
- Indications HIV infections
- Focus Adverse reactions; Therapeutic Use
- 31 May 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 31 May 2012 Actual patient number (95) added as reported by ClinicalTrials.gov.
- 30 Mar 2011 New trial record